Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03178617 · ClinicalTrials.gov registry record · NA

High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

A NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
214
Enrollment target
3
Study locations

NCT03178617: Active NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, sponsored by City of Hope Medical Center.

NCT03178617 is a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 214 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (86% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03178617, a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
214 participants
Enrollment target
3
Study locations

Study Summary

This randomized clinical trial studies how well a high-intensity intervention parenting program works in improving learning and school functioning in Latino children with acute leukemia or lymphoblastic lymphoma. A high-intensity intervention program may help doctors to see whether training parents or caregivers in specific parenting skills and "pro-learning" behaviors will result in better learning and school outcomes for Latino children with acute leukemia or lymphoblastic lymphoma. It is not yet known if a high-intensity intervention program is more beneficial than a standard of care lower intensity parenting intervention.

Primary Outcome

Measured by the parent-reported Pediatric Quality of Life Inventory school domain.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Educational Intervention

Study Locations (3)

California

  • City of Hope Medical Center - Duarte
  • Children's Hospital Los Angeles - Los Angeles
  • Children's Hospital of Orange County - Orange

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2018-02-14
Est. Completion 2026-10-27
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT03178617 still lists

NCT03178617 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (86% higher).

The record links to 4 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03178617 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03178617 about?

NCT03178617 is a clinical study titled "High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma". This randomized clinical trial studies how well a high-intensity intervention parenting program works in improving learning and school functioning in Latino children with acute leukemia or lymphoblastic lymphoma. A high-intensity intervention program may help doctors to see whether training parents ...

What is the current status of trial NCT03178617?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2018-02-14. Estimated completion is 2026-10-27.

What conditions does trial NCT03178617 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia, Lymphoblastic Lymphoma.

What interventions are being tested in trial NCT03178617?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT03178617?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03178617 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03178617's enrollment target sits among peer trials

214 42nd of 306 higher than 265 of 306 other Acute Myeloid Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Myeloid Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04030507 · 214 participants · NA

    Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

  • NCT04421248 · 214 participants · Phase 4

    Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

  • NCT04667520 · 214 participants · NA

    Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment

  • NCT05418868 · 214 participants · Phase 1

    A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03178617, the US trial registry maintained by the National Library of Medicine. NCT03178617 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.